Gosset Ownership
Private
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
CytoReason General Information
No direct clinical results; the company provides predictive models that help pharmaceutical partners shorten trial phases and increase likelihood of drug approval. Five of the world's top ten pharma companies use their technology.
Contact Information
Website
Primary Industry
Drug Discovery Services
Corporate Office
Tel Aviv,
Israel
Israel
Drug Pipeline
No pipeline data available
Key Partnerships
Pfizer, OurCrowd, NVIDIA, Thermo Fisher Scientific, PICO Partners
CytoReason Funding
No funding data available
To view CytoReason's complete valuation and funding history, request access »